413826.fig.001a
(a)
413826.fig.001b
(b)
413826.fig.001c
(c)
413826.fig.001d
(d)
Figure 1: Serum SDMA concentrations in critically ill patients. (a) At admission to the medical ICU, serum SDMA levels were significantly ( , test) elevated in critically ill patients ( ) as compared to healthy controls ( ). (b) SDMA serum levels at ICU admission were significantly increased in ICU patients with sepsis ( ) compared to patients without sepsis ( ). (c) SDMA serum levels at ICU admission were significantly increased in ICU patients with higher degree of disease severity, as displayed by the APACHE-II score. (d) In 42 patients, SDMA levels were measured at admission (day 1) and at 1 week (day 7) of ICU therapy. SDMA levels remained stable during the first week of ICU treatment (paired Wilcoxon test).